Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $11,847 | $35,640 | $33,269 | $20,395 |
| G&A Expenses | $7,499 | $9,618 | $10,348 | $10,008 |
| SG&A Expenses | $7,499 | $9,618 | $10,348 | $10,008 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $3,190 | $1,871 | $0 |
| Operating Expenses | $19,347 | $48,448 | $45,489 | $30,403 |
| Operating Income | -$19,347 | -$48,448 | -$45,489 | -$30,403 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,185 | -$887 | $405 | -$2,319 |
| Pre-Tax Income | -$16,162 | -$49,335 | -$45,084 | -$32,722 |
| Tax Expense | -$2,969 | -$409 | -$2,884 | $0 |
| Net Income | -$13,192 | -$48,926 | -$42,200 | -$32,722 |
| % Margin | – | – | – | – |
| EPS | -107.348 | -616.072 | -594.75 | -465.52 |
| % Growth | 82.6% | -3.6% | -27.8% | – |
| EPS Diluted | -107.348 | -616.072 | -594.75 | -465.52 |
| Weighted Avg Shares Out | 123 | 79 | 76 | 70 |
| Weighted Avg Shares Out Dil | 123 | 79 | 76 | 70 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,247 | $9 | $10 | $9 |
| Depreciation & Amortization | $31 | $67 | $77 | $86 |
| EBITDA | -$14,884 | -$49,258 | -$44,996 | -$32,627 |
| % Margin | – | – | – | – |